Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Tipo de documento
Ano de publicação
Intervalo de ano de publicação
1.
Nat Commun ; 9(1): 2371, 2018 06 18.
Artigo em Inglês | MEDLINE | ID: mdl-29915258

RESUMO

Chordoid glioma (ChG) is a characteristic, slow growing, and well-circumscribed diencephalic tumor, whose mutational landscape is unknown. Here we report the analysis of 16 ChG by whole-exome and RNA-sequencing. We found that 15 ChG harbor the same PRKCA D463H mutation. PRKCA encodes the Protein kinase C (PKC) isozyme alpha (PKCα) and is mutated in a wide range of human cancers. However the hot spot PRKCA D463H mutation was not described in other tumors. PRKCA D463H is strongly associated with the activation of protein translation initiation (EIF2) pathway. PKCαD463H mRNA levels are more abundant than wild-type PKCα transcripts, while PKCαD463H is less stable than the PCKαWT protein. Compared to PCKαWT, the PKCαD463H protein is depleted from the cell membrane. The PKCαD463H mutant enhances proliferation of astrocytes and tanycytes, the cells of origin of ChG. In conclusion, our study identifies the hallmark mutation for chordoid gliomas and provides mechanistic insights on ChG oncogenesis.


Assuntos
Neoplasias do Ventrículo Cerebral/genética , Glioma/genética , Proteína Quinase C-alfa/genética , Adulto , Idoso , Proliferação de Células , Células Cultivadas , Neoplasias do Ventrículo Cerebral/metabolismo , Feminino , Glioma/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Mutação Puntual , Proteína Quinase C-alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA